News
Investing.com -- AbbVie (NYSE: ABBV) shares climbed over 3% in premarket trading Friday after the drugmaker lifted its ...
Despite trimming its 2026 EPS forecast by about 6% due to softer expectations in short-cycle markets, Citi maintained a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback